Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow margin | 15.3% | 14.2% | 11.4% | 18.1% | 23.8% | 24.1% | 26.0% | 27.2% | 23.8% | 26.7% | 30.8% | 29.5% | 35.8% | 29.1% | 28.8% | 29.1% | 23.5% | 33.8% | 36.2% | 30.1% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 24.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for Novo Nordisk A/S have been 31.2% over the past three years, and 32.6% over the past five years.
As of today, Novo Nordisk A/S's Free Cash Flow margin is 24.9%, which is higher than industry median of (743.0%). It indicates that Novo Nordisk A/S's Free Cash Flow margin is Good.